Last119.25 -4.80 (-3.87%)
73.4 - 193.54
52 Week Range
Technical Indicators (Daily)
While Zai Lab (NASDAQ:ZLAB) shareholders have made 571% in 3 years, increasing losses might now be front of mind as stock sheds 6.3% this week
It hasn't been the best quarter for Zai Lab Limited ( NASDAQ:ZLAB ) shareholders, since the share price has fallen 19......
Tao Fu, President And COO at Zai Lab (NASDAQ:ZLAB), made a large buy and sell of company shares on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities ...
SHANGHAI and SAN FRANCISCO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, announced today that it will expand...
Potential first-in-class therapy for a subset of gastric and gastroesophageal (GEJ) cancers that overexpress fibroblast growth factor receptor 2 (FGFR2b)SHANGHAI and SAN FRANCISCO, Sept. 14, 2021 (GLO...
Harald Reinhart, Chief Medical Officer at Zai Lab (NASDAQ:ZLAB), made a large buy and sell of company shares on September 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S....
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.